Literature DB >> 25899624

Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats.

Robyn Mary Brown1, Andrezza K Kim1,2, Shaun Yon-Seng Khoo1,3, Jee Hyun Kim1, Bianca Jupp1,4, Andrew John Lawrence1.   

Abstract

Orexins (hypocretins) are hypothalamic neuropeptides that innervate the entire neuraxis, including the prelimbic cortex and ventral tegmental area and have been implicated in ethanol-seeking behaviour. The present study aimed to use the orexin-1 (OX1 ) receptor antagonist SB-334867 to examine the role of prelimbic cortex and ventral tegmental area OX1 receptors in cue-induced reinstatement of ethanol-seeking. Ethanol-preferring rats (iP) rats were trained to self-administer ethanol (10 percent v/v, FR3) or sucrose (0.2-1 percent w/v, FR3) in the presence of reward-associated cues before being implanted with indwelling guide cannulae. Rats then underwent extinction training for 11 days. On test days, rats were given a microinjection of vehicle or SB-334867 (3 μg/side) and presented with reward-associated cues to precipitate reinstatement. Results show SB-334867 infused into the prelimbic cortex attenuated cue-induced reinstatement of ethanol-seeking, but not sucrose-seeking. OX1 antagonism in the ventral tegmental area also attenuated cue-induced reinstatement of ethanol-seeking. These findings suggest that OX1 receptors located in the prelimbic cortex and ventral tegmental area are part of a circuit driving cue-mediated ethanol-seeking behaviour.
© 2015 Society for the Study of Addiction.

Entities:  

Keywords:  Cue-induced reinstatement; SB-334867; ethanol; orexin; prelimbic cortex; ventral tegmental area

Mesh:

Substances:

Year:  2015        PMID: 25899624     DOI: 10.1111/adb.12251

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  21 in total

1.  Anterior Insular Cortex is Critical for the Propensity to Relapse Following Punishment-Imposed Abstinence of Alcohol Seeking.

Authors:  Erin J Campbell; Jeremy P M Flanagan; Leigh C Walker; Mitchell K R I Hill; Nathan J Marchant; Andrew J Lawrence
Journal:  J Neurosci       Date:  2018-12-03       Impact factor: 6.167

Review 2.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

3.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Brain Res       Date:  2016-10-19       Impact factor: 3.252

4.  Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.

Authors:  Manuel Sanchez-Alavez; Jessica Benedict; Derek N Wills; Cindy L Ehlers
Journal:  Sleep       Date:  2019-04-01       Impact factor: 5.849

5.  The Role of Orexin Signaling in the Ventral Tegmental Area and Central Amygdala in Modulating Binge-Like Ethanol Drinking Behavior.

Authors:  Jeffrey J Olney; Montserrat Navarro; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2017-02-09       Impact factor: 3.455

6.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

Review 7.  The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.

Authors:  David E Moorman
Journal:  Psychopharmacology (Berl)       Date:  2018-03-06       Impact factor: 4.530

8.  Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice.

Authors:  Kelly Lei; Scott A Wegner; Ji-Hwan Yu; F Woodward Hopf
Journal:  Neuropharmacology       Date:  2016-08-11       Impact factor: 5.250

Review 9.  Medications for alcohol use disorders: An overview.

Authors:  Mohammed Akbar; Mark Egli; Young-Eun Cho; Byoung-Joon Song; Antonio Noronha
Journal:  Pharmacol Ther       Date:  2017-12-02       Impact factor: 12.310

10.  PSPH-D-18-00526: Effect of a dual orexin receptor antagonist (DORA-12) on sleep and event-related oscillations in rats exposed to ethanol vapor during adolescence.

Authors:  Cindy L Ehlers; Jessica Benedict; Derek Wills; Manuel Sanchez-Alavez
Journal:  Psychopharmacology (Berl)       Date:  2019-10-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.